EP2305245
Meðferð við sjúkdómum er tengjast notkun fúkkalyfja
:
EP einkaleyfi í gildi á Íslandi:
13.5.2005:
2.1.2019:
10075450.6
:
27.2.2019:
15.3.2019
:
12.5.2025:
12.5.2025
:
Treatment of diseases associated with the use of antibiotics
13.5.2005
2.1.2019
27.2.2019
15.3.2019
12.5.2025
:
Merck Sharp & Dohme LLC:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
:
Shue, Youe-Kong:
CarlsbadCalifornia, US
:
Babakhani, Farah Kondori:
San DiegoCalifornia, US
:
Okumu, Franklin W.:
OaklandCalifornia, US
:
Sears, Pamela Suzanne:
San DiegoCalifornia, US
:
Miller-Shangle, Starr Louise:
San DiegoCalifornia, US
:
Walsh, Robert Brian:
DavisCalifornia, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
570697 P:
14.5.2004:
US
:
A61K 31/335, A61K 31/7048, A61K 31/365, A61P 1/12, A61K 45/06
: 15
: 1.3.2019
: 12.5.2020
: G. H. Sigurgeirsson
: 16
: 14.4.2020
: 12.5.2021
: Örn Þór slf.
: 17
: 12.4.2021
: 12.5.2022
: Örn Þór slf.
: 18
: 22.4.2022
: 12.5.2023
: Árnason Faktor ehf.
: 19
: 12.4.2023
: 12.5.2024
: Árnason Faktor ehf.
: 20
: 12.4.2024
: 12.5.2025
: Árnason Faktor ehf.